Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-10-14 5:12 pm Purchase | 2021-10-13 | 13G | CIDARA THERAPEUTICS INC CDTX | Point72 Asset Management, L.P. | 210,000 6.300% | 210,000 (New Position) | Filing History |
| 2021-10-07 5:24 pm Purchase | 2021-10-06 | 13G | PRAXIS PRECISION MEDICINES INC PRAX | Point72 Asset Management, L.P. | 168,712 5.700% | 168,712 (New Position) | Filing History |
| 2021-09-21 4:51 pm Purchase | 2021-09-17 | 13G | AVALO THERAPEUTICS INC AVTX | Point72 Asset Management, L.P. | 2,087 5.400% | 2,087 (New Position) | Filing History |
| 2021-09-21 4:34 pm Purchase | 2021-09-20 | 13G | PROTAGONIST THERAPEUTICS INC C PTGX | Point72 Asset Management, L.P. | 4,329,030 9.100% | 4,329,030 (New Position) | Filing History |
| 2021-09-13 4:56 pm Purchase | 2021-09-10 | 13G | GROWTH CAP ACQUISITION CORP GCAC | Point72 Asset Management, L.P. | 1,080,424 6.300% | 1,080,424 (New Position) | Filing History |
| 2021-09-07 4:35 pm Purchase | 2021-08-25 | 13G | THERAVANCE BIOPHARMA INC TBPH | Point72 Asset Management, L.P. | 5,144,637 7.000% | 5,144,637 (New Position) | Filing History |